Fernanda Yanez Regonesi

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Fernanda Yanez Regonesi sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Fernanda Yanez Regonesi: 1 sponsored US clinical trial, 1 recruiting.

Fernanda Yanez Regonesi sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is OSA, with 1 trials.

Mid-pack sponsor footprint

Fernanda Yanez Regonesi is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Mandibular Advancement Device and Changes in Nocturia

NCT05562388

Therapeutic Areas

OSA 1
Nocturia 1
Obstructive Sleep Apnea 1

What is open in the Fernanda Yanez Regonesi pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: OSA (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Fernanda Yanez Regonesi: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Fernanda Yanez Regonesi sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Fernanda Yanez Regonesi1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Fernanda Yanez Regonesi sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Fernanda Yanez Regonesi sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Fernanda Yanez Regonesi page

1 registered trials is a research-attention snapshot, not an endorsement of Fernanda Yanez Regonesi or any single study.

  • 1 of Fernanda Yanez Regonesi's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • OSA is the condition Fernanda Yanez Regonesi studies most, compare against other sponsors active in the same condition before evaluating a specific study. See OSA trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Fernanda Yanez Regonesi pipeline card: 1 registered trials from official public datasets.Report a data error.